SI2097064T1 - Anaplerotična terapija huntingtonove bolezni in drugih poliglutaminskih bolezni - Google Patents
Anaplerotična terapija huntingtonove bolezni in drugih poliglutaminskih bolezniInfo
- Publication number
- SI2097064T1 SI2097064T1 SI200731703T SI200731703T SI2097064T1 SI 2097064 T1 SI2097064 T1 SI 2097064T1 SI 200731703 T SI200731703 T SI 200731703T SI 200731703 T SI200731703 T SI 200731703T SI 2097064 T1 SI2097064 T1 SI 2097064T1
- Authority
- SI
- Slovenia
- Prior art keywords
- huntington disease
- polyglutamine diseases
- anaplerotic therapy
- anaplerotic
- therapy
- Prior art date
Links
- 208000023105 Huntington disease Diseases 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 229920000155 polyglutamine Polymers 0.000 title 1
- 108010040003 polyglutamine Proteins 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/035—Organic compounds containing oxygen as heteroatom
- A23L29/04—Fatty acids or derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06291873A EP1929995A1 (en) | 2006-12-04 | 2006-12-04 | Anaplerotic therapy of Huntington disease and other polyglutamine diseases |
| PCT/EP2007/063181 WO2008068230A1 (en) | 2006-12-04 | 2007-12-03 | Anaplerotic therapy of huntington disease and other polyglutamine diseases |
| EP07847692.6A EP2097064B1 (en) | 2006-12-04 | 2007-12-03 | Anaplerotic therapy of huntington disease and other polyglutamine diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2097064T1 true SI2097064T1 (sl) | 2016-01-29 |
Family
ID=37733780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200731703T SI2097064T1 (sl) | 2006-12-04 | 2007-12-03 | Anaplerotična terapija huntingtonove bolezni in drugih poliglutaminskih bolezni |
Country Status (11)
| Country | Link |
|---|---|
| US (5) | US20100063147A1 (sl) |
| EP (3) | EP1929995A1 (sl) |
| CY (1) | CY1116938T1 (sl) |
| DK (1) | DK2097064T3 (sl) |
| ES (2) | ES2552843T3 (sl) |
| HK (1) | HK1223829A1 (sl) |
| HU (1) | HUE026217T2 (sl) |
| PL (1) | PL2097064T3 (sl) |
| PT (1) | PT2097064E (sl) |
| SI (1) | SI2097064T1 (sl) |
| WO (1) | WO2008068230A1 (sl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1929995A1 (en) | 2006-12-04 | 2008-06-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Anaplerotic therapy of Huntington disease and other polyglutamine diseases |
| JP5765839B2 (ja) * | 2009-12-05 | 2015-08-19 | 国立大学法人名古屋大学 | 球脊髄性筋萎縮症治療薬 |
| AR079733A1 (es) * | 2009-12-30 | 2012-02-15 | Baylor Res Inst | Terapia anaplerotica para la enfermedad de alzheimer y el envejecimiento cerebral |
| WO2011159634A1 (en) * | 2010-06-14 | 2011-12-22 | Baylor Research Institute | Triheptanoin diet for adult polyglucosan body disease (apbd) treatment |
| CN104955450A (zh) * | 2012-12-13 | 2015-09-30 | 达拉斯贝勒研究院 | 用于治疗葡萄糖转运体1缺乏症的三庚酸甘油酯 |
| WO2015073803A1 (en) | 2013-11-14 | 2015-05-21 | The University Of Queensland | Neurodegenerative disorders and methods of treatment and diagnosis thereof |
| US20170161441A1 (en) * | 2014-07-02 | 2017-06-08 | Ridge Diagnostics, Inc. | Methods and materials for treating pain and depression |
| CN117298092A (zh) | 2016-06-08 | 2023-12-29 | 善睿圣医药保健股份有限公司 | 具有奇数碳的脂类化合物及其作为医药组合物或者营养补充剂的用途 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4025649A (en) | 1974-08-19 | 1977-05-24 | Labaz | Acetic acid derivatives having pharmacological activity and compositions containing the same |
| DE3032300A1 (de) | 1980-08-27 | 1982-04-01 | Alfred Ing. Wien Lohninger | Mittel zur parenteralen ernaehrung |
| GB2104079B (en) | 1981-08-14 | 1985-08-21 | London Polytech | New aminoacid isomers, their production and their medicinal use |
| US4753963A (en) | 1985-09-26 | 1988-06-28 | The Procter & Gamble Company | Nutritional fat suitable for enteral and parenteral products |
| JP3486778B2 (ja) | 1993-04-02 | 2004-01-13 | 三菱ウェルファーマ株式会社 | アルツハイマー病予防治療剤 |
| US20090253781A1 (en) | 2002-05-24 | 2009-10-08 | Btg International Limited | Therapeutic compositions |
| JP4902906B2 (ja) * | 1999-02-05 | 2012-03-21 | ベイラー リサーチ インスティテュート | 炭素数が７である脂肪酸を含むトリグリセリドを含有する栄養補助剤または医薬調製物 |
| US6740679B1 (en) * | 1999-02-05 | 2004-05-25 | Baylor University Medical Center | Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid |
| WO2001032168A1 (en) | 1999-11-03 | 2001-05-10 | Juvenon, Inc. | Method of treating benign forgetfulness |
| ES2323940T3 (es) | 2000-05-01 | 2009-07-28 | Accera, Inc. | Uso de trigliceridos de cadena media para el tratamiento y prevencion de la enfermedad de alzheimer. |
| US6835750B1 (en) * | 2000-05-01 | 2004-12-28 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II |
| JP2006519843A (ja) * | 2003-03-06 | 2006-08-31 | アクセラ・インコーポレーテッド | 新規化学物質及び代謝異常の治療におけるそれらの使用法 |
| EP1628622A4 (en) | 2003-05-20 | 2008-12-17 | Baylor Res Inst | FIVE AND FIFTH CARBON FATTY ACIDS FOR THE TREATMENT OF METABOLISM DISORDERS AND AS FOOD SUPPLEMENTS |
| CA2784585A1 (en) | 2004-07-02 | 2006-02-09 | Baylor Research Institute | Glycogen or polysaccharide storage disease treatment method |
| WO2006037069A1 (en) | 2004-09-28 | 2006-04-06 | Allergan, Inc. | Compositions comprising nb-dnj, ne-dnj or d-glucaro-delta-lactam and their uses for the treatment of pain and other neurological conditions |
| HUE040002T2 (hu) | 2006-04-03 | 2019-02-28 | Accera Inc | Ketogén vegyületek alkalmazása korfüggõ memóriazavar kezelésére |
| CN101573107A (zh) | 2006-09-26 | 2009-11-04 | 贝勒研究院 | 营养传感器 |
| EP1929995A1 (en) | 2006-12-04 | 2008-06-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Anaplerotic therapy of Huntington disease and other polyglutamine diseases |
| PT2650380E (pt) | 2007-07-31 | 2016-01-14 | Accera Inc | Utilização de testagem genómica e compostos cetogénicos para o tratamento de função cognitiva reduzida |
| WO2009124250A1 (en) | 2008-04-03 | 2009-10-08 | The Trustees Of The University Of Pennsylvania | Compositions and methods for detecting tricarboxylic acid (tca) metabolic flux |
| AR079733A1 (es) | 2009-12-30 | 2012-02-15 | Baylor Res Inst | Terapia anaplerotica para la enfermedad de alzheimer y el envejecimiento cerebral |
| US20110301238A1 (en) | 2010-06-02 | 2011-12-08 | Borges Karin | Seizure related disorders and therapeutic methods thereof |
| WO2011159634A1 (en) | 2010-06-14 | 2011-12-22 | Baylor Research Institute | Triheptanoin diet for adult polyglucosan body disease (apbd) treatment |
| EP3372228A1 (en) | 2010-12-23 | 2018-09-12 | Amazentis SA | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders |
| CN104955450A (zh) | 2012-12-13 | 2015-09-30 | 达拉斯贝勒研究院 | 用于治疗葡萄糖转运体1缺乏症的三庚酸甘油酯 |
| WO2015073803A1 (en) | 2013-11-14 | 2015-05-21 | The University Of Queensland | Neurodegenerative disorders and methods of treatment and diagnosis thereof |
-
2006
- 2006-12-04 EP EP06291873A patent/EP1929995A1/en not_active Withdrawn
-
2007
- 2007-12-03 US US12/516,486 patent/US20100063147A1/en not_active Abandoned
- 2007-12-03 EP EP07847692.6A patent/EP2097064B1/en active Active
- 2007-12-03 SI SI200731703T patent/SI2097064T1/sl unknown
- 2007-12-03 PT PT78476926T patent/PT2097064E/pt unknown
- 2007-12-03 HU HUE07847692A patent/HUE026217T2/en unknown
- 2007-12-03 WO PCT/EP2007/063181 patent/WO2008068230A1/en active Application Filing
- 2007-12-03 ES ES07847692.6T patent/ES2552843T3/es active Active
- 2007-12-03 EP EP15175719.2A patent/EP3009135B1/en active Active
- 2007-12-03 PL PL07847692T patent/PL2097064T3/pl unknown
- 2007-12-03 ES ES15175719T patent/ES2778525T3/es active Active
- 2007-12-03 DK DK07847692.6T patent/DK2097064T3/en active
-
2011
- 2011-12-30 US US13/341,028 patent/US20120165405A1/en not_active Abandoned
-
2014
- 2014-06-19 US US14/308,966 patent/US9717705B2/en active Active
-
2015
- 2015-11-13 CY CY20151101025T patent/CY1116938T1/el unknown
-
2016
- 2016-10-20 HK HK16112074.6A patent/HK1223829A1/zh unknown
-
2017
- 2017-06-30 US US15/640,018 patent/US10220014B2/en active Active
-
2019
- 2019-02-04 US US16/267,210 patent/US20190365695A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PT2097064E (pt) | 2015-11-25 |
| ES2552843T3 (es) | 2015-12-02 |
| PL2097064T3 (pl) | 2016-02-29 |
| US20180021287A1 (en) | 2018-01-25 |
| CY1116938T1 (el) | 2017-04-05 |
| EP3009135B1 (en) | 2020-02-05 |
| EP2097064B1 (en) | 2015-08-19 |
| HK1223829A1 (zh) | 2017-08-11 |
| EP3009135A1 (en) | 2016-04-20 |
| ES2778525T3 (es) | 2020-08-10 |
| US10220014B2 (en) | 2019-03-05 |
| US20190365695A1 (en) | 2019-12-05 |
| US20140364498A1 (en) | 2014-12-11 |
| US20120165405A1 (en) | 2012-06-28 |
| HUE026217T2 (en) | 2016-05-30 |
| US20100063147A1 (en) | 2010-03-11 |
| DK2097064T3 (en) | 2015-11-23 |
| EP2097064A1 (en) | 2009-09-09 |
| WO2008068230A1 (en) | 2008-06-12 |
| US9717705B2 (en) | 2017-08-01 |
| EP1929995A1 (en) | 2008-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2182983A4 (en) | TREATMENT OF AMYLOIDOGENIC DISEASES | |
| PT2097064E (pt) | Terapia anaplerótica de doença de huntington e de outras doenças de poliglutamina | |
| EP1968607A4 (en) | TREATMENT OF CANCER AND OTHER DISEASES | |
| PT2056863T (pt) | Tratamento de doenças oculares | |
| BRPI0720046A2 (pt) | Composição de suplemento nutricional para tratamento de doenças oculares | |
| HK1131047A1 (en) | Treatment of inflammatory diseases | |
| HK1201046A1 (en) | Methods of treating ophthalmic diseases | |
| PL2056842T3 (pl) | Modyfikowany galaktozyloceramid do leczenia chorób nowotworowych | |
| EP1962839A4 (en) | ADMINISTRATION OF A MNTOR INHIBITOR FOR THE TREATMENT OF PATIENTS WITH CANCER | |
| EP2004204A4 (en) | TREATMENT OF NEURODEGENERATIVE DISEASES | |
| EP2160100B8 (en) | Treatment of graft-versus-host disease | |
| HK1148684A1 (en) | Treatment of prion protein related diseases | |
| ZA200806808B (en) | Treatment of stressed patients | |
| EP1962869A4 (en) | TREATMENT OF RESPIRATORY DISEASES | |
| EP2026822A4 (en) | TOPICAL TREATMENT FOR EYE SURGERY DISEASES | |
| GB0610183D0 (en) | Treatment of neurodegenerative diseases | |
| EP2001488A4 (en) | PREVENTION AND TREATMENT OF CANCER AND OTHER DISEASES | |
| PL2056858T3 (pl) | Leczenie stanów chorobowych płuc | |
| EP2049899A4 (en) | METHOD FOR THE PREVENTION AND TREATMENT OF DISEASES | |
| GB2458868A8 (en) | Treatment of protein aggregation diseases | |
| BRPI0821539A2 (pt) | composição para a prevenção e o tratamento de doenças metabólicas compreendendo o extrato de lysimachiae foenum-graeci herma | |
| EP2025342A4 (en) | THERAPEUTIC AGENT OR DEVELOPMENT INHIBITOR OF POLYGLUTAMINE DISEASE | |
| EP2059238A4 (en) | THERAPEUTIC COMPOUNDS FOR DISEASES AND DISORDERS | |
| GB0623740D0 (en) | Treatment of disease | |
| GB0622136D0 (en) | Treatment of gastrointestinal diseases |